Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity.

Telomerase activity (TA) is detected in most human cancers but, with few exceptions, not in normal somatic cells. Little is known about TA in soft tissue tumors. We have examined a series of benign and malignant soft tissue tumors for TA using the telomerase repeat amplification protocol assay. Analysis of the expression of the human telomerase reverse transcriptase was also carried out using RT-PCR. TA was undetectable in benign lesions (15 of 15) and low-grade sarcomas (6 of 6) and was detectable in 50% (19 of 38) of intermediate-/high-grade sarcomas. Although the presence of TA in soft tissue tumors is synonymous with malignancy, it is neither a reliable method in making the distinction between reactive/benign and malignant (especially low-grade) lesions nor a reliable marker of tumor aggressiveness. Leiomyosarcomas and storiform/pleomorphic malignant fibrous histiocytomas rarely showed TA, irrespective of their grade. A strong correlation between human telomerase reverse transcriptase mRNA expression and TA was observed, supporting the close relationship between both parameters. No significant relationship was observed between proliferative activity (as assessed by MIB-1 immunolabeling) and TA. We verified that the absence of telomerase expression was not due to the presence of telomerase inhibitors and therefore alternative mechanism(s) for cell immortalization, yet to be determined, seem to be involved in the development and/or maintenance of some soft tissue sarcomas.

[1]  Hisatomi,et al.  Telomerase activity in human renal cell carcinoma , 1999, International journal of urology : official journal of the Japanese Urological Association.

[2]  F. Bosman,et al.  Tissue quality is an important determinant of telomerase activity as measured by TRAP assay. , 1998, BioTechniques.

[3]  L. Giudice,et al.  Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. , 1998, Cancer research.

[4]  M. Erlanson,et al.  Telomerase activity in Hodgkin's disease. , 1998, Blood.

[5]  K. Shroyer,et al.  Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling. , 1998, Journal of clinical pathology.

[6]  S. Kyo,et al.  Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. , 1998, Cancer research.

[7]  R. Weinberg,et al.  Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase , 1998, Oncogene.

[8]  D. Wallwiener,et al.  Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer , 1998, International journal of cancer.

[9]  R. Schneider-Stock,et al.  On telomere shortening in soft-tissue tumors , 1998, Journal of Cancer Research and Clinical Oncology.

[10]  E. Dmitrovsky,et al.  High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. , 1997, Journal of the National Cancer Institute.

[11]  J. Murnane,et al.  Immortalized cells with no detectable telomerase activity. A review. , 1997, Biochemistry. Biokhimiia.

[12]  D. S. Coffey,et al.  Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. , 1997, Biochemistry. Biokhimiia.

[13]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[14]  D. Bowtell,et al.  Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. , 1997, Human molecular genetics.

[15]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[16]  Y. Konishi,et al.  Increased telomerase activity is not directly related to metastatic potential in rat transplantable osteosarcomas. , 1997, Cancer letters.

[17]  Nam W. Kim,et al.  Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) , 1997, Nucleic Acids Res..

[18]  J. Kononen,et al.  Short Communication Increased Expression of Telomerase RNA Component Is Associated with Increased Cell Proliferation in Human Astrocytomas , 2007 .

[19]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[20]  J. Shay,et al.  Telomerase activity in ordinary meningiomas predicts poor outcome. , 1997, Human pathology.

[21]  A. Gazdar,et al.  Telomerase in the early detection of cancer. , 1997, Journal of clinical pathology.

[22]  June Corwin,et al.  Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .

[23]  P. Brousset,et al.  Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. , 1997, Blood.

[24]  B. Gallie,et al.  Development of retinoblastoma in the absence of telomerase activity. , 1996, Journal of the National Cancer Institute.

[25]  J. Shay,et al.  Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. , 1995, Nucleic acids research.

[26]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[27]  J. Shay,et al.  Telomerase activity in gastric cancer. , 1995, Cancer research.

[28]  Keiko Hiyama,et al.  Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.

[29]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[30]  D. Weiss.  Histological Typing of Soft Tissue Tumours , 1994, World Health Organization.